Key result
Guideline-directed prescription of aspirin and statins for primary prevention in diabetic patients was achieved in 36.2% and 63.1% of indicated cases, respectively.
Cross-Sectional (n=312)
No
There is a significant gap in the implementation of guideline-recommended aspirin and statin therapy for primary cardiovascular prevention in diabetic patients.
Answers are grounded in this paper and cite their sources.
Suboptimal guideline-directed aspirin and statin prescriptions in diabetes signal care gaps; leaves open optimal implementation strategies amid weak evidence.
OBJECTIVE: To ascertain whether recommendations for the use of Statins and Aspirin as primary prevention in diabetic patients are correctly implemented at our institution. METHODS: This cross-sectional study was conducted between February 2014 and April 2014 at the General Practice Department of King Abdulaziz University Hospital. Three hundred twelve patients were included in the study. Data were collected from the electronic patient medical records for the characteristics of the patients, existing co-morbidities, and results of laboratory investigations. Descriptive statistics were performed for all variables. RESULTS: Of 312 patients, aspirin was indicated for 17.0% but it was not prescribed. It was both indicated and prescribed in 36.2% of the cases. Statin treatment was indicated in 27.2% of the patients but it was not prescribed, while in 63.1% of cases it was indicated and prescribed. CONCLUSION: The proportion of patients who achieved treatment targets at our institution is greater than that reported by other studies, albeit treatment targets are not being met in a significant number of cases.
No takes yet. Share an insight, caveat, or question.
Alkhail et al. (2016) conducted a cross-sectional in Diabetes mellitus (primary prevention of cardiovascular diseases) (n=312). Aspirin and Statins was evaluated on Correct implementation of recommendations for the use of Statins and Aspirin (prescription when indicated). Guideline-directed prescription of aspirin and statins for primary prevention in diabetic patients was achieved in 36.2% and 63.1% of indicated cases, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: